Preparing for tomorrow: Defining a future agenda. (22nd March 2022)

• Record Type: Journal Article
• Authors: O'Mahony, Brian; Wong, Olivier; Eichler, Hermann; Neumann, Peter; Carlsson, Katarina Steen; Noone, Declan
• Is Part Of: Haemophilia. Volume 28(2022)Supplement 2
• Page Start: 35
• Page End: 41
• Publication Date: 2022-03-22
• Subjects: gene therapy -- haemophilia -- health technology assessment -- payment -- value; Hemophilia -- Periodicals; 616.1572005
• DOI: 10.1111/hae.14476
• Languages: English
• ISSNs: 1351-8216

Abstract

Abstract: Gene therapy will be the first long‐term therapy with potential to produce a functional cure for haemophilia. As a single dose ('once‐and‐done') therapy with significant uncertainties regarding impact and duration of factor expression, flexibility and adaptability of (1) value framework, (2) health technology assessment (HTA) methodology, and (3) development of alternative payment models will be needed for adoption of this new technology and to facilitate transparent decision‐making to support its implementation. The responsibility for each of these currently lies with distinct entities, underscoring a need for enhanced collaboration between all stakeholders, as expanded engagement by key stakeholders will be critical to optimizing the assessment of value, enabling an optimised approach to HTA, and opening receptivity to new and innovative payment models. This supplement issue describes important considerations for a gene therapy 'toolkit', highlighting key considerations for each of the aforementioned tools, which will be useful for guiding decision‐making regarding gene therapy as a novel treatment modality. In this article, we outline how the tools presented in this supplement can be applied as part of a framework to address the requirements of the relevant stakeholders, including payers, manufacturers, treaters, and patients. The paper also provides an illustrative example of how to understand the features of alternative payment models depending on the organization of and payment for healthcare.